Biography of Gudarz Davar
Last update: November 25, 2023Career
Gudarz was Executive Vice President and Head of Research and Development at Acadia Pharmaceuticals, and Vice President, Neurology Development at Eli Lilly.
Gudarz Davar is currently- Executive Vice President and Chief Medical Officer at Autobahn Therapeutics - View - Autobahn Therapeutics org chart
- Director at Kisbee Therapeutics - View - Kisbee Therapeutics org chart
Create your alert
to follow the career of Gudarz Davar.
Education
Gudarz Davar has a Doctor of Medicine from Dalhousie University.
They have also studied at Dalhousie University :
Find more alumni from Dalhousie University
More about Gudarz Davar
Selected links
Do you need to know more about Gudarz Davar? More results.
Participate
Social media
- Gudarz Davar on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Gudarz Davar
The colleagues of Gudarz Davar
Company Colleagues
- At Autobahn Therapeutics, Gudarz Davar has 12 colleagues including Kevin Finney (CEO & Chairman), Scott Giacobello (Director)…
- At Kisbee Therapeutics, Gudarz Davar has 11 colleagues including Matt Ottmer (CEO), Thomas Cahill (Director)…
Industry Colleagues
- In the Biotechnology industry, Gudarz Davar has 30,319 colleagues in 2,286 companies located in 40 countries. 14,359 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Gudarz Davar.
Get in Touch
and ask for Gudarz Davar.
